Patent · US Active

Anti-TIM-3 antibodies and uses thereof

US11214615B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignee

Phanes Therapeutics, Inc. · US

Inventors

Minghan Wang · Newbury Park, US
Hui Zou · Chengdu City, CN

Key dates

Filing date	Jul 26, 2018
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Nov 6, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70503
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-TIM-3 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, an inflammatory disease, an autoimmune disease, a metabolic disease, and/or infectious diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.